Welcome to our newest Start-up Partner, Nervosave Therapeutics!
We are excited to have Nervosave join us in our mission to improve the lives of people witih peripheral nerve problems!
Nervosave Therapeutics develops a platform of local gene therapies that slow, stop and reverse a broad range of diseases involving peripheral nerves.
Their first aim is to develop best in class gene therapy for Charcot-Marie-Tooth (CMT) disease 1A and beyond for all CMT diseases.
Nervosave Therapeutics is developing a platform that has game-changing potential in several devastating diseases with clear therapeutic needs such as neuralgias, diabetic peripheral neuropathy and other degenerative diseases involving nerves.
Please join us in welcoming Nervosave Therapeutics and to learn more visit: https://nervosavetx.com/